BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33317447)

  • 1. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.
    Dehghannasiri R; Freeman DE; Jordanski M; Hsieh GL; Damljanovic A; Lehnert E; Salzman J
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15524-15533. PubMed ID: 31308241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors.
    Buckley J; Schmidt RJ; Ostrow D; Maglinte D; Bootwalla M; Ruble D; Govindarajan A; Ji J; Kovach AE; Orgel E; Raca G; Navid F; Mascarenhas L; Pawel B; Robison N; Gai X; Biegel JA
    J Mol Diagn; 2024 Feb; 26(2):127-139. PubMed ID: 38008288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
    Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
    BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.
    Vats P; Chinnaiyan AM; Kumar-Sinha C
    Methods Mol Biol; 2020; 2079():69-79. PubMed ID: 31728962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SFyNCS detects oncogenic fusions involving non-coding sequences in cancer.
    Zhong X; Luan J; Yu A; Lee-Hassett A; Miao Y; Yang L
    Nucleic Acids Res; 2023 Oct; 51(18):e96. PubMed ID: 37638762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.
    Paciello G; Ficarra E
    BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FusionGDB: fusion gene annotation DataBase.
    Kim P; Zhou X
    Nucleic Acids Res; 2019 Jan; 47(D1):D994-D1004. PubMed ID: 30407583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FuSpot: a web-based tool for visual evaluation of fusion candidates.
    Killian JA; Topiwala TM; Pelletier AR; Frankhouser DE; Yan PS; Bundschuh R
    BMC Genomics; 2018 Feb; 19(1):139. PubMed ID: 29439649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer.
    Abate F; Zairis S; Ficarra E; Acquaviva A; Wiggins CH; Frattini V; Lasorella A; Iavarone A; Inghirami G; Rabadan R
    BMC Syst Biol; 2014 Sep; 8():97. PubMed ID: 25183062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering and understanding oncogenic gene fusions through data intensive computational approaches.
    Latysheva NS; Babu MM
    Nucleic Acids Res; 2016 Jun; 44(10):4487-503. PubMed ID: 27105842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
    Hernandez A; Muñoz-Mármol AM; Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí-Lluciá O; Martinez-García M; Mallo M; Gut M; Del Barco S; Gallego O; Dabad M; Mesia C; Bellosillo B; Domenech M; Vidal N; Aldecoa I; de la Iglesia N; Balana C
    Sci Rep; 2022 Aug; 12(1):14439. PubMed ID: 36002559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
    Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.